System pH-Sensitive mPEG-Hz-Cholesterol Conjugates as a Liposome Delivery

Hydrazone (Hz)-based pH-sensitive methoxy(polyethylene glycol)-cholesterol conjugates (mPEG-Hz-Chol), were synthesized and used to fabricate liposomes. The structures of the mPEG2000-Hz-Chol conjugate were confirmed by FT-IR and H-NMR; they were stable at pH 7.4 but sensitive to mild acid conditions (pH 5.5). Plain liposomes were also prepared with S100PC/ Chol, and the pH-insensitive liposomes with S100PC/Chol/mPEG2000-Chol for comparison; all the liposomes were similar in diameter 200 nm. In vitro, the pH-sensitive liposomes released more of the model drug, paclitaxel (PTX), than the plain liposomes. The pH-sensitive liposomes were less toxic than the plain liposomes and exhibited higher cellular uptake of PTX compared with pH-insensitive liposomes by human breast cancer cells (MCF-7). The pHsensitive mPEG2000-Hz-Chol liposomes are now being investigated as a potential new liposome drug delivery system.

[1]  J. Desbrières,et al.  Hydrogels Based on Carboxymethylcellulose and Gelatin for Inclusion and Release of Chloramphenicol , 2009 .

[2]  F. Veronese,et al.  A Biodegradable Polymeric Carrier Based on PEG for Drug Delivery , 2009 .

[3]  K. Uhrich,et al.  Amphiphilic Scorpion-like Macromolecules as Micellar Nanocarriers , 2008 .

[4]  Eugene Lih,et al.  An In Situ Gel-Forming Heparin-Conjugated PLGA-PEG-PLGA Copolymer , 2008 .

[5]  Zengjuan Zheng,et al.  Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles. , 2008, Colloids and surfaces. B, Biointerfaces.

[6]  Q. Guo,et al.  Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. , 2008, Biomaterials.

[7]  Dipak K. Sarker,et al.  Effects of poly (ethylene glycol) chains conformational transition on the properties of mixed DMPC/DMPE-PEG thin liquid films and monolayers. , 2007, Colloids and surfaces. B, Biointerfaces.

[8]  Dae-Duk Kim,et al.  Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[9]  L. Yu,et al.  Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives. , 2007, Colloids and surfaces. B, Biointerfaces.

[10]  V. Torchilin,et al.  “Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes , 2007, Journal of liposome research.

[11]  Z. Zhou,et al.  In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. , 2005, International journal of pharmaceutics.

[12]  D. Thompson,et al.  Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[13]  D. Aggarwal,et al.  Paclitaxel and its formulations. , 2002, International journal of pharmaceutics.

[14]  T. Allen,et al.  Targeting Stealth liposomes in a murine model of human small cell lung cancer. , 2001, Biochimica et biophysica acta.

[15]  J Verweij,et al.  Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. , 2001, European journal of cancer.

[16]  R. Panchagnula Pharmaceutical aspects of paclitaxel , 1998 .

[17]  R. Straubinger,et al.  Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia. , 1996, Cancer letters.

[18]  A. Gabizon,et al.  Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. , 1991, Biochimica et biophysica acta.

[19]  J. Zhang,et al.  Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.